RecallDepth
Class II Ongoing

Losartan Potassium Tablets USP 50 mg 50 tablets (5x10) Unit Dose Rx Only NDC 50268-517-15 Manufactured for: AvKARE Inc. Pulaski, TN 38478

This recall is currently active, issued May 8, 2019. It was issued by Avkare Inc..

Company
Avkare Inc.
Recall Initiated
April 24, 2019
Posted
May 8, 2019
Recall Number
D-1249-2019
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
1438 cartons (71,900 tablets)
Firm Location
Pulaski, TN, United States
Official Source
View on FDA website ↗

Reason for Recall

CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level of 0.96 parts per million.

Distribution

Nationwide

Lot / Code Info

Lot: 20121 Exp. 6/30/2019

More recalls by Avkare Inc.

View all recalls by this company →

Other recent Class II Drug recalls